Immuneoncia Therapeutics, Inc.
Overview
Immuneoncia Therapeutics, Inc. is a South Korean biotechnology company focused on developing innovative immuno-oncology therapies. The company aims to enhance the efficacy of cancer treatments by harnessing the body's immune system. With a robust pipeline, Immuneoncia is committed to advancing cancer care through its research and development efforts.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Immuneoncia Therapeutics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.